End-stage kidney disease (ESKD) is a common and morbid disease that affects patients'
quality and length of life, representing a large portion of health care expenditure in the …

Vascular access outcomes in hemodialysis are critically important for patients and clinicians,
but frequently are neither patient relevant nor measured consistently in randomized trials. A …

There are an estimated 14,000 randomized trials published in chronic kidney disease. The
most frequently reported outcomes are biochemical endpoints, rather than clinical and …

Rationale & Objective Optimizing vascular access use is crucial for long-term hemodialysis
patient care. Because vascular access use varies internationally, we examined international …

Tools that measure patients' experiences and perceptions of disease are increasingly being
recognized as important components of a multidisciplinary personalized approach to care …

Background Vascular access outcomes reported across haemodialysis (HD) trials are
numerous, heterogeneous and not always relevant to patients and clinicians. This study …

Background: A self-administered 11 item vascular access specific quality of life measure
(VASQoL) was previously derived from detailed qualitative interviews with adult patients with …

Background Controversy exists regarding the best-performing vascular access type for
patients undergoing haemodialysis. We aimed to compare outcomes of starting dialysis on …

Background Twenty to 60% of newly created hemodialysis arteriovenous fistulas do not
mature adequately for use. One barrier to developing interventions to improve fistula …

Objectives: To summarize existing evidence on the quality of life and influencing factors in
maintenance hemodialysis (MHD) patients. Methods: Total 122 MHD patients treated in the …